Efficacy of aflibercept in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema: a prospective study
IVA is effective for DME regardless of vitreous status, with similar efficacy and treatment frequency in vitrectomized and non-vitrectomized eyes. DEX implantation produces anatomical benefits in IVA-refractory cases, although visual gains are limited.
Authors
- Ferenc Rárosi (ORCID: https://orcid.org/0000-0002-1014-9242)
- G. Thury
- Nikolett Baranyi (ORCID: https://orcid.org/0000-0002-6518-5689)
- Attila Kovács (ORCID: https://orcid.org/0000-0002-4383-2929)
- Rebeka Héjja
Institutions
- University of Szeged (HU)
Publication Details
- Journal
- International Journal of Retina and Vitreous
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s40942-025-00778-y
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00